We are live on ! Find out more
PARN

Parnell Pharmaceuticals Holdings Ltd
PARN

Delisted

PARN was delisted on the 30th of December, 2016.

Back to rankings

2 hedge funds and large institutions have $181K invested in Parnell Pharmaceuticals Holdings Ltd in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% less capital invested

Capital invested by funds: $1.17M → $181K (-$992K)

90% less funds holding

Funds holding: 20 → 2 (-18)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 15

Holders
2
Holders Change
-18
Holders Change %
-90%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
Sabby Management
Florida
+$2.67K

Top Sellers

1
ECM
Endurant Capital Management
California
-$227K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$102K
3
BlackRock
BlackRock
New York
-$63K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$25K
5
VKH
Virtu KCG Holdings
New York
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$181K +$2.67K +3,000 +1%
ECM
2
Endurant Capital Management
California
– -$227K -328,781 Closed
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
– -$102K -147,458 Closed
BlackRock
4
BlackRock
New York
– -$63K -91,911 Closed
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
– -$25K -36,817 Closed
VKH
6
Virtu KCG Holdings
New York
– -$15K -21,417 Closed
Fidelity Investments
7
Fidelity Investments
Massachusetts
– -$14K -20,140 Closed
Cambridge Investment Research Advisors
8
Cambridge Investment Research Advisors
Iowa
– -$14K -19,999 Closed
AP
9
Atwood & Palmer
Missouri
– -$12K -16,900 Closed
Goldman Sachs
10
Goldman Sachs
New York
– -$7K -10,451 Closed
MSTVIM
11
Messner & Smith Theme Value Investment Management
California
– -$7K -10,000 Closed
LTFS
12
Ladenburg Thalmann Financial Services
Florida
– -$4K -6,800 Closed
Morgan Stanley
13
Morgan Stanley
New York
– -$1K -2,000 Closed
AG
14
Advisor Group
Arizona
– -$1K -1,507 Closed

PARN Hedge Fund Activity: Q1 2017 in Review

2 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q1 2017, worth a combined $181K — down 85% from $1.17M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of PARN and 0 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, adding an estimated $2.67K. The largest seller was Endurant Capital Management, exiting entirely with an estimated $227K sold.

  • 2 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q1 2017, down from 20 in Q4 2016.
  • Funds reported $181K of Parnell Pharmaceuticals Holdings Ltd stock for Q1 2017, down 85% quarter-over-quarter.
  • 0 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q1 2017 and 15 closed out, a net change of -15 holders.
  • The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q1 2017 was Sabby Management, an estimated $2.67K added.
  • The largest Parnell Pharmaceuticals Holdings Ltd seller in Q1 2017 was Endurant Capital Management, an estimated $227K sold.

Based on aggregated 13F filings for Q1 2017.